ACTN3 genotypes of Rugby Union players: Distribution, power output and body composition

Annals of Human Biology

Volumn 39, Issue 1, 2012, Pages 19-27

  Bell, W ^a   Colley, J P ^b   Evans, W D ^c   Darlington, S E ^c   Cooper, S M ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

actinin 3; Body composition; Power output; Rugby union

Indexed keywords

ACTININ; ACTN3 PROTEIN, HUMAN;

BODY CONDITION; BODY SHAPE; BONE; COVARIANCE ANALYSIS; ENZYME ACTIVITY; FAT; GENOTYPE; MUSCLE; PHENOTYPE; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; SPORT; STATISTICAL ANALYSIS; X-RAY SPECTROSCOPY;

ADOLESCENT; ADULT; ARTICLE; ATHLETE; BIOMECHANICS; BODY COMPOSITION; CASE CONTROL STUDY; FEMALE; FOOTBALL; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; MALE;

ACTININ; ADOLESCENT; ATHLETES; BIOMECHANICS; BODY COMPOSITION; CASE-CONTROL STUDIES; FEMALE; FOOTBALL; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; YOUNG ADULT;

EID: 83455201713     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.3109/03014460.2011.632648     Document Type: Article

References (41)

1. Ahmetov II, Druzhevskaya AM, Astratenkova IV, Popov DV, Vinogradova OL, Rogozkin VA. 2010. The ACTN3 R577poly-morphism in Russian endurance athletes. Brit J Sports Med 44: 649-652.
2. Bell W, Evans WD, Cobner DM, Eston RG. 2005. The regional placement ofbone mineral mass, fat mass, and lean soft tissue mass in young adult Rugby Union players. Ergonomics 48:1462-1472. (Pubitemid 43347817)
3. Blanchard A, Ohanian V, Critchley D. 1989. The structure and function ofα-actinin. J Mus Res Cell Motility 10:280-289.
4. Booth FW, Lees SJ. 2006. Physically active subjects should be the control group. Med Sci Sports Exerc 38:405-406. (Pubitemid 43364112)
5. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, Price TB, Angelopoulos TJ, Gordon PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, Seip RL, Hoffman EP. 2005. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J App Physiol 99:154-163. (Pubitemid 40934477)
6. Djinovic-Carugo K, Gautel M, Yianne J, Young P. 2002. The spectrin repreat; a structural platform for cytoskeleton protein assemblies. FEBS Lett 513:119-123. (Pubitemid 34242988)
7. Doring FE, Onur S, Geisen U, Boulay MR, Perusse L, Rankinen T, Rauramaa R, Wolfahrt B, Bouchard C. 2010. ACTN3 R577X and other polymorphisms are not associated with elite endurance athlete status in the Genathlete study. J Sport Sci 28:1355-1359.
8. Druzhevskaya AM, Ahmetov II, Astratenkova IV, Rogozkin VA. 2008. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J App Physiol 103:631-634.
9. Duthie G, Pyne D, Hooper S. 2003. Applied physiology and game analysis of Rugby Union. Sports Med 33:973-991.
10. Eynon N, Duarte JA, Oliveira J, Sagiv M, Yamin C, Meckel Y, Sagiv M, Goldhammer E. 2009. ACTN3 R557X polymorphism and Israeli top-level athletes. Int J Sports Med 11:839-842.
11. Gomez-Gallego F, Santiago C, Gonzalez-Freire M, Muniesa CA, Fernandez del Valle M, Perez M, Foster C, Lucia A. 2009. Endurance performance: genes or gene combinations? Int J Sports Med 30: 66-72.
12. Gore SM, Altman DG. 1982. How large a sample? In: Gore SM, Altman DG, editors. Statistics and ethics in medical practice. London: British Medical Association. p 6-8.
13. Hanson ED, Ludlow AT, Sheaff AK, Park J, Roth SM. 2010. ACTN3 genotype does not influence muscle power. Int J Sports Med 31: 834-838.
14. Jardine MA, Wiggins TM, Myburgh KH, Noakes TD. 1988. Physiological characteristics of rugby players including muscle glycogen content and muscle fibre composition. South Afr Med J 73: 529-532.
15. Linthorne NP. 2001. Analysis ofstanding vertical jumps using a force platform. Am J Phys 69:1198-1204.
16. Lucia A, Gomez-Gallego F, Santiago C, Bandres F, Earnest C, Rabadan M, Alonso JM, Hoyos J, Cordova A, Villa G, Foster C. 2006. ACTN3 genotype in professional endurance cyclists. Int J Sports Med 27: 1-5.
17. Mac Arthur DG, North KN. 2004. A gene for speed? The evolution and function ofα-actinin-3. Bio Essays 26:786-795. (Pubitemid 38987612)
18. Mac Arthur DG, North KN. 2007. ACTN3: a genetic influence on muscle function and athletic performance. Exerc Sport Sci Rev 35: 30-34. (Pubitemid 46071917)
19. Mac Arthur DG, Seto JT, Chan S, Quinlan KGR, Raftery JM, Turner N, Nicholson MD, Kee AJ, Hardeman EC, Gunning PW, Cooney GJ, Head SI, Yang N, North KN. 2008. An ACTN3 knockout mouse provides mechanistic insights into the association between α-actinin-3 deficiency and human athletic performance. Hum Mol Genet 17:1076-1086. (Pubitemid 351494181)
20. Mac Arthur DG, Seto JT, Rafterty JM, Quinlan KG, Huttley GA, Hook JW, Lemckert FA, Kee AJ, Edwards MR, Bermam Y, Hardeman EC, Gunning PW, Easteal S, Yang N, North KN. 2007. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence ofpositive selection in humans. Nat Genet 39:1261-1265. (Pubitemid 47482687)
21. Mc Cauley T, Mastana SS, Folland JP. 2010. ACE I/D and ACTN3 R/X polymorphism and muscle function and muscularity of older Caucasian men. Eur J Appl Physiol 109:269-277.
22. Mills M, Yang N, Weinberger R, Douglas L, Woude V, Beggs AH, Easteal S, North K. 2001. Differential expression of the acting binding proteins, α-actinin-2 and-3, in different species: implications for the evolution of functional redundancy Hum Mol Genet 10:1335-1346. (Pubitemid 32640662)
23. Moran CN, Yang N, Bailey MES, Tsiokanos A, Jamurtas A, Mac Arthur DG, North K, Pitsiladis YP, Wilson RH. 2007. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet 15:88-93. (Pubitemid 44921671)
24. Niemi A-K, Majamaa K. 2005. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 13:965-969. (Pubitemid 41131745)
25. Norman B, Esbjornsson M, Rundqvist H, Osterlund T, von Walden F, Tesch PA. 2009. Strength, power, fibre types, and m RNA expression in trained men and women with different ACTN3 R577X genotypes. J Appl Physiol 106:959-965.
26. North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH. 1999. A common nonsense mutation results in α-actinin-3 deficiency in the general population. Nat Genet 21:353-354. (Pubitemid 29159565)
27. Papadimitriou ID, Papadopoulos C, Kouvatsi A, Triantaphyllidis C. 2008. The ACTN3 gene in elite Greek track and field athletes. Int J Sports Med 29:352-355. (Pubitemid 351542898)
28. Roberts SP, Trewartha G, Higgitt RJ, El-abd J, Stokes KA. 2008. The physical demands of elite English rugby union. J Sport Sci 26: 825-833. (Pubitemid 351935674)
29. Rodriguez-Romo G, Ruiz JR, Santiago C, Fiuza-Luces C, Gonzalez-Freire M, Gomez-Gallego F, Moran M, Lucia A. 2010. Does the ACE I/D polymorphism alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults? Eur J Appl Physiol 110:1099-1106.
30. Roth SM, Walsh S, Liu D, Metter EJ, Ferrucci L, Hurley BF. 2008. The ACTN3 R577X allele is under represented in elite-level strength athletes. Eur J Hum Genet 16:391-394. (Pubitemid 351292240)
31. Ruiz JR, Fernandez del Valle M, Verde Z, Diez-Vega I, Santiago C. 2010. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scan J Med Sci Sports. (EPub ahead of print).
32. Santiago C, Gonzalez-Freire M, Serratosa L, Morate FJ, Meyer T, Gomez-Gallego F, Lucia A. 2008. ACTN3 genotype in professional soccer players. Brit J Sports Med 42:71-73. (Pubitemid 351158215)
33. Santiago C, Rodriguez-Romo G, Gomez-Gallego F, Gonzalez-Freire M, Yvert T, Verde Z, Naclerio F, Altmae S, Esteve-Lanao J, Ruiz JR, Lucia A. 2010. Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults? Scan J Med Sci Sports 20:771-778.
34. Saunders CJ, September AV, Xenophontos SL, Cariolou MA, Anastassiades LC, Noakes TD, Collins M. 2007. No association of the ACTN3 gene R577X polymorphism with endurance perform-ance in Ironman triathletes. Ann Hum Genet 71:777-781. (Pubitemid 47517262)
35. Van Damme R, Wilson RS, Vanhooydonk B, Aerts P. 2002. Performance constraints in decathletes. Nature 415:755-756.
36. Vincent B, De Bock K, Ramaeckers M, Van den Eede E, Van Leemputte M, Hespel P, Thomis MA. 2007. ACTN3 (R577X) genotype is associated with fibre type distribution. Physiol Genomics 32:58-63.
37. Walsh S, Liu D, Metter EJ, Ferrucci L, Roth SM. 2008. ACTN3 genotype is associated with muscle phenotypes in women across the adult age span. J Appl Physiol 105:1486-1491.
38. Yang N, Garton F, North K. 2009. α-actinin-3 and performance. In: Collins M, editor. Genetics and Sports. London: Karger. p 88-101.
39. Yang N, Mac Arthur DG, Gulbin JP, Allan G, Hahn AG, Beggs AH, Easteal S, North K. 2003. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73:627-631. (Pubitemid 37076274)
40. Yang N, Mac Arthur DG, Wolde B, Onywera VO, Boit MK, Lau SYM, Wilson RH, Scott RA, Pitsiladis YP, North K. 2007. The ACTN3 R577X polymorphism in East and West African athletes. Med Sci Sports Exerc 39:1985-1988. (Pubitemid 350073362)
41. Yang N, Schindeler A, Mc Donald MM, Seto JT, Houweling PJ, Lek M, Hogarth M, Morse AR, Raftery JM, Balasuriya D, Mac Arthur DG, Berman Y, Eisman JA, Nguyen TV, Center JR, Prince RL, Wilson SG, Zhu K, Little DG, North KN. 2011. α-actinin-3 deficiency is associated with reduced bone mass in human and mouse. Bone 49: 790-798.